We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Cerner Shakes Up IT Sector by Acquiring Siemens’ Health Information Services

By MedImaging International staff writers
Posted on 07 Aug 2014
Print article
Cerner Corporation (Waltham, MA, USA) and Siemens AG (Munich, Germany) have entered into a definitive agreement for Cerner to acquire Siemens' Health Information Technology (IT) business unit, Siemens Health Services, for USD 1.3 billion in cash. The two companies will have a combined total of USD 4.5 billion annual revenue, as well as USD 650 million in annual research and development funds. As part of the agreement, Cerner and Siemens will form a strategic alliance to bring new solutions to market that combine Cerner's health IT leadership and Siemens' strengths in medical devices and imaging.

In part of Kalorama's (New York, NY, USA) EMR market report earlier this year, Siemens is one of the companies that has moved away from electronic medical records in favor of other systems. The move should help Cerner build its place over its rivals McKesson, Epic, and Allscripts.

This agreement is a strategic alliance of a three-year term combining investments in R&D, knowledgeable resources, and complementary client bases. Each company will contribute up to USD 50 million to fund projects of shared importance, aimed at rapidly achieving the next generation of clinical computing to deliver precision medicine at higher quality and lower costs.

For Siemens, the move is one more indication that Siemens may be backing off some parts of its healthcare portfolio. Earlier in the year, the company sold its microbiology testing unit to rival Beckman Coulter.

Given these companies’ strategies, as outlined in Kalorama’s (New York, NY, USA; www.kalorama.com) market for electronic medical records (EMR) Markets 2014, none of these developments is surprising. Cerner is committed to an open healthcare ecosystem able to send and receive data in a universal manner, strongly believing in the proposal that EMRs are not a one-size-fits-all proposition. Siemens Medical Solutions strategy for growth has been based on finding complementary technology that enables Siemens to offer complete solutions.

Neal Patterson, Cerner chairman, CEO and co-founder, comments, "We believe this is an all-win situation for the clients of both organizations and all of our associates and shareholders. Through more than USD 4 billion of cumulative investments in R&D, Cerner has established a strong market standing and is positioned for continued growth. Siemens' health care IT assets provide additional scale, R&D, an impressive client base, and knowledgeable and experienced associates who will help Cerner achieve our plans for the next decade. In addition, the alliance we're creating will drive the next generation of innovations that embed information from the EMR inside advanced diagnostic and therapeutic technologies, benefitting our shared clients."

Related Links:

Cerner Corporation
Siemens
Kalorama


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound System
Voluson Signature 18
New
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.